David F. Nickerson
Pfizer (United States)(US)
Publications by Year
Research Areas
Growth Hormone and Insulin-like Growth Factors, Estrogen and related hormone effects, Organometallic Complex Synthesis and Catalysis, Metal complexes synthesis and properties, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Discovery and Preclinical Pharmacology of a Novel, Potent, Nonsteroidal Estrogen Receptor Agonist/Antagonist, CP-336156, a Diaryltetrahydronaphthalene(1998)131 cited
- → Monitoring the quality of conduct of clinical trials: a survey of current practices(2011)92 cited
- → Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs)(2003)47 cited
- → Preclinical Pharmacology of CP-424,391, an Orally Active Pyrazolidinone-Piperidine Growth Hormone Secretagogue(2001)40 cited
- → Binding of Fluvastatin to Blood Cells and Plasma Proteins(1993)38 cited
- → Discovery and biological characterization of capromorelin analogues with extended half-lives(2002)29 cited
- → Theoretical study of cis-trans isomerization in simple transition-metal complexes(1985)19 cited
- → The effect of oral dose volume on the absorption of a highly and a poorly water soluble drug in the rat(1994)11 cited
- → Intraperitoneal and intraportal administration of droloxifene to the Sprague-Dawley rat: assessing the first-pass effect(1997)9 cited
- → First-pass metabolism and biliary recirculation of droloxifene in the female Sprague- Dawley rat(1997)7 cited